Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Chernik

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Clinical Psychopharmacology|August 1, 1990
Sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: an introductionL C Johnson, D A Chernik, M J Sateia
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 1, 1997
Strategies for revealing dangerous concentrations of radon in buildingsV C Titov, D P Lashkov, I M Khaykovich, et al.
Journal of Clinical Pharmacology|October 1, 1987
Efficacy without tolerance or rebound insomnia for midazolam and temazepam after use for one to three monthsR P Allen, J Mendels, D B Nevins, et al.
Journal of Clinical Psychopharmacology|February 1, 1992
Validity and reliability of the Neurobehavioral Assessment ScaleD A Chernik, M Tucker, B Gigli, et al.
Journal of Clinical Psychopharmacology|August 1, 1990
Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolamD A Chernik, D Gillings, H Laine, et al.
Neurology|January 1, 1997
Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group IM C Kurth, C H Adler, M S Hilaire, et al.
Journal of Clinical Psychopharmacology|August 1, 1990
A multicenter study of sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: executive summaryD Chen, D A Chernik, E Ellinwood, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1994
Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessmentC G Goetz, G T Stebbins, H M Shale, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Clinical Psychopharmacology|August 1, 1990
Sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: an introductionL C Johnson, D A Chernik, M J Sateia
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 1, 1997
Strategies for revealing dangerous concentrations of radon in buildingsV C Titov, D P Lashkov, I M Khaykovich, et al.
Journal of Clinical Pharmacology|October 1, 1987
Efficacy without tolerance or rebound insomnia for midazolam and temazepam after use for one to three monthsR P Allen, J Mendels, D B Nevins, et al.
Journal of Clinical Psychopharmacology|February 1, 1992
Validity and reliability of the Neurobehavioral Assessment ScaleD A Chernik, M Tucker, B Gigli, et al.
Journal of Clinical Psychopharmacology|August 1, 1990
Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolamD A Chernik, D Gillings, H Laine, et al.
Neurology|January 1, 1997
Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group IM C Kurth, C H Adler, M S Hilaire, et al.
Journal of Clinical Psychopharmacology|August 1, 1990
A multicenter study of sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: executive summaryD Chen, D A Chernik, E Ellinwood, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1994
Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessmentC G Goetz, G T Stebbins, H M Shale, et al.
Pageof 2